Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2. - Coleman N; Wei Z; Iafrate AJ; Zwiebel JA; Sharon E; Gray RJ; Wang V; McShane LM; Rubinstein LV; Patton DR; Williams PM; Hamilton SR; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2026)